Multiwave Locked System (MLS) Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

Status: Completed
Location: See location...
Intervention Type: Other, Device
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• COVID-19 positive

• Pulmonary compromise requiring oxygen support of approximately 2-6 liters

• Able to self prone, or support in self-sitting position

Locations
United States
Massachusetts
Lowell General Hospital
Lowell
Time Frame
Start Date: 2020-04-30
Completion Date: 2020-07-16
Participants
Target number of participants: 10
Treatments
Experimental: Experimental
Participants will receive MLS laser treatment along with regular inpatient medical care.
Active_comparator: Control Group
Participants will receive regular inpatient medical care.
Sponsors
Leads: Lowell General Hospital

This content was sourced from clinicaltrials.gov